Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

1.

Penetration of topical chloramphenicol into the anterior chamber: response.

Cagini C, Piccinelli F, Lupidi M, Messina M, Cerqualglia A, Manes S, Fiore T, Pellegrino RM.

Clin Experiment Ophthalmol. 2014 Nov 6. doi: 10.1111/ceo.12471. [Epub ahead of print] No abstract available.

PMID:
25376245
[PubMed - as supplied by publisher]
2.

Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors.

Gómez-Moutón C, Fischer T, Peregil RM, Jiménez-Baranda S, Stossel TP, Nakamura F, Mañes S.

Blood. 2014 Oct 29. pii: blood-2014-09-601807. [Epub ahead of print]

PMID:
25355818
[PubMed - as supplied by publisher]
3.

CX3CL1 at the crossroad of EGF signals: Relevance for the progression of ERBB2+ breast carcinoma.

Tardáguila M, Mañes S.

Oncoimmunology. 2013 Sep 1;2(9):e25669. Epub 2013 Jul 9.

PMID:
24319638
[PubMed]
Free PMC Article
4.

A lovastatin-elicited genetic program inhibits M2 macrophage polarization and enhances T cell infiltration into spontaneous mouse mammary tumors.

Mira E, Carmona-Rodríguez L, Tardáguila M, Azcoitia I, González-Martín A, Almonacid L, Casas J, Fabriás G, Mañes S.

Oncotarget. 2013 Dec;4(12):2288-301.

PMID:
24317954
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Notch activation stimulates migration of breast cancer cells and promotes tumor growth.

Bolós V, Mira E, Martínez-Poveda B, Luxán G, Cañamero M, Martínez-A C, Mañes S, de la Pompa JL.

Breast Cancer Res. 2013;15(4):R54.

PMID:
23826634
[PubMed - in process]
Free PMC Article
6.

CX3CL1 promotes breast cancer via transactivation of the EGF pathway.

Tardáguila M, Mira E, García-Cabezas MA, Feijoo AM, Quintela-Fandino M, Azcoitia I, Lira SA, Mañes S.

Cancer Res. 2013 Jul 15;73(14):4461-73. doi: 10.1158/0008-5472.CAN-12-3828. Epub 2013 May 29.

PMID:
23720051
[PubMed - indexed for MEDLINE]
Free Article
7.

A novel in vitro sperm head decondensation protocol for rapid flow cytometric measurement of deoxyribonucleic acid content.

Antonucci N, Manes S, Corradetti B, Manicardi GC, Borini A, Bizzaro D.

Fertil Steril. 2013 Jun;99(7):1857-61. doi: 10.1016/j.fertnstert.2013.02.014. Epub 2013 Mar 15.

PMID:
23498889
[PubMed - indexed for MEDLINE]
8.

Ocular penetration of topical antibiotics: study on the penetration of chloramphenicol, tobramycin and netilmicin into the anterior chamber after topical administration.

Cagini C, Piccinelli F, Lupidi M, Messina M, Cerqualglia A, Manes S, Fiore T, Pellegrino RM.

Clin Experiment Ophthalmol. 2013 Sep-Oct;41(7):644-7. doi: 10.1111/ceo.12087. Epub 2013 Apr 11.

PMID:
23433257
[PubMed - indexed for MEDLINE]
9.

CCR5 in cancer immunotherapy: More than an "attractive" receptor for T cells.

González-Martín A, Mira E, Mañes S.

Oncoimmunology. 2012 Jan 1;1(1):106-108.

PMID:
22720226
[PubMed]
Free PMC Article
10.

CCR5 as a potential target in cancer therapy: inhibition or stimulation?

González-Martin A, Mira E, Mañes S.

Anticancer Agents Med Chem. 2012 Nov;12(9):1045-57. Review.

PMID:
22583417
[PubMed - indexed for MEDLINE]
11.

APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase.

Zonca M, Mancheño-Corvo P, DelaRosa O, Mañes S, Büscher D, Lombardo E, Planelles L.

Tissue Eng Part A. 2012 Apr;18(7-8):852-9. doi: 10.1089/ten.TEA.2011.0316. Epub 2011 Dec 22.

PMID:
22059379
[PubMed - indexed for MEDLINE]
12.

Maximal T cell-mediated antitumor responses rely upon CCR5 expression in both CD4(+) and CD8(+) T cells.

González-Martín A, Gómez L, Lustgarten J, Mira E, Mañes S.

Cancer Res. 2011 Aug 15;71(16):5455-66. doi: 10.1158/0008-5472.CAN-11-1687. Epub 2011 Jun 29.

PMID:
21715565
[PubMed - indexed for MEDLINE]
Free Article
13.

Morphometric characteristics and chromatin integrity of spermatozoa in three Italian dog breeds.

Lange-Consiglio A, Antonucci N, Manes S, Corradetti B, Cremonesi F, Bizzaro D.

J Small Anim Pract. 2010 Dec;51(12):624-7. doi: 10.1111/j.1748-5827.2010.01001.x.

PMID:
21121916
[PubMed - indexed for MEDLINE]
14.

Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: a cohort study.

Romero-Gómez M, Jover M, Del Campo JA, Royo JL, Hoyas E, Galán JJ, Montoliu C, Baccaro E, Guevara M, Córdoba J, Soriano G, Navarro JM, Martínez-Sierra C, Grande L, Galindo A, Mira E, Mañes S, Ruiz A.

Ann Intern Med. 2010 Sep 7;153(5):281-8. doi: 10.7326/0003-4819-153-5-201009070-00002.

PMID:
20820037
[PubMed - indexed for MEDLINE]
15.

Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains.

Vieira CR, Munoz-Olaya JM, Sot J, Jiménez-Baranda S, Izquierdo-Useros N, Abad JL, Apellániz B, Delgado R, Martinez-Picado J, Alonso A, Casas J, Nieva JL, Fabriás G, Mañes S, Goñi FM.

Chem Biol. 2010 Jul 30;17(7):766-75. doi: 10.1016/j.chembiol.2010.05.023.

PMID:
20659689
[PubMed - indexed for MEDLINE]
Free Article
16.

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

Caffarel MM, Andradas C, Mira E, Pérez-Gómez E, Cerutti C, Moreno-Bueno G, Flores JM, García-Real I, Palacios J, Mañes S, Guzmán M, Sánchez C.

Mol Cancer. 2010 Jul 22;9:196. doi: 10.1186/1476-4598-9-196.

PMID:
20649976
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

An isoform-specific PDZ-binding motif targets type I PIP5 kinase beta to the uropod and controls polarization of neutrophil-like HL60 cells.

Mañes S, Fuentes G, Peregil RM, Rojas AM, Lacalle RA.

FASEB J. 2010 Sep;24(9):3381-92. doi: 10.1096/fj.09-153106. Epub 2010 May 4.

PMID:
20442317
[PubMed - indexed for MEDLINE]
Free Article
18.

Liver and brain imaging through dimercaptosuccinic acid-coated iron oxide nanoparticles.

Mejías R, Pérez-Yagüe S, Roca AG, Pérez N, Villanueva A, Cañete M, Mañes S, Ruiz-Cabello J, Benito M, Labarta A, Batlle X, Veintemillas-Verdaguer S, Morales MP, Barber DF, Serna CJ.

Nanomedicine (Lond). 2010 Apr;5(3):397-408. doi: 10.2217/nnm.10.15.

PMID:
20394533
[PubMed - indexed for MEDLINE]
19.

Web-based data management for a phase II clinical trial in ALS.

Buchsbaum R, Kaufmann P, Barsdorf AI, Arbing R, Montes J, Thompson JL; QALS Study Group.

Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):374-7. doi: 10.3109/17482960802378998.

PMID:
19922127
[PubMed - indexed for MEDLINE]
20.

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.

Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS, Katz J, Rollins Y, Barohn RJ, Jackson CE, Tiryaki E, Lomen-Hoerth C, Armon C, Tandan R, Rudnicki SA, Rezania K, Sufit R, Pestronk A, Novella SP, Heiman-Patterson T, Kasarskis EJ, Pioro EP, Montes J, Arbing R, Vecchio D, Barsdorf A, Mitsumoto H, Levin B; QALS Study Group.

Ann Neurol. 2009 Aug;66(2):235-44. doi: 10.1002/ana.21743.

PMID:
19743457
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk